New cancer clinical trial: Phase II Study of Palbociclib and Cetuximab in KRAS/NRAS/BRAF Wild-type mCRC

Published on: February 26, 2018 at 12:00PM
Conditions:   Cancer of the Colon;   Colon Cancer;   Colon Neoplasms;   Colonic Cancer;   Neoplasms, Colonic
Interventions:   Drug: Cetuximab;   Drug: Palbociclib
Sponsors:   UNC Lineberger Comprehensive Cancer Center;   Amgen;   Pfizer
Not yet recruiting
http://ift.tt/2BSDweU